Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid peroxidation inhibition refers to strategies aimed at preventing or reducing oxidative damage to lipids within cell membranes caused by reactive oxygen species. This process is central in many diseases involving oxidative stress and tissue damage. Inhibition can be achieved through direct scavenging of radicals by antioxidants, enzymatic detoxification pathways, or reinforcement of membrane lipids against oxidation. The primary products are lipid hydroperoxides which can further degrade into toxic aldehydes such as malondialdehyde and 4-hydroxynonenal if unchecked.
Neutralization of free radicals and reactive oxygen species to prevent initiation or propagation of lipid peroxidation chain reactions; enzymatic reduction of hydroperoxides by selenoproteins and other enzymes. Drugs act as radical scavengers or enhance endogenous antioxidant defenses.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid peroxidation inhibition.